Autologous stem cell transplantation in solid tumours of childhood

Annals of Medicine

Volumn 28, Issue 2, 1996, Pages 159-164

  Atra, Ayad ^a   Pinkerton, C Ross ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Ewing's sarcoma and children; High dose chemoradiotherapy; Neuroblastoma; Peripheral blood stem cell transplantation; Rhabdomyosarcoma

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MAFOSFAMIDE; MELPHALAN; THIOTEPA; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; AUTOTRANSPLANTATION; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; EWING SARCOMA; HUMAN; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; REMISSION; REVIEW; RHABDOMYOSARCOMA; SOLID TUMOR; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 0029874830     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899609092941     Document Type: Review

References (43)

1. Clifford P, Clift RA, Duff JK. Nitrogen mustard therapy combined with autologous marrow infusion. Lancet 1961; 1: 687-90.
2. Fernandez JM, Shepherd V, Millar J, Powles R, Pinkerton CR. When is the optimum time to harvest peripheral blood stem cells in children following standard dose chemotherapy? Med Pediatr Oncol 1993; 21: 465-9.
3. Demeocq F, Kanold J, Chassagne J, Bezou MJ, et al. Successful blood stem cell collection and transplant in children weighing less than 25 kg. Bone Marrow Transplant 1994; 13: 43-50.
4. Moss TJ, Cairo M, Santant VM, Weinthal J, et al. Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation. Blood 1994; 83: 3085-9.
5. Kushner BH, Helson L. Co-ordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma. Experience with 100 patients. J Clin Oncol 1987; 5: 1746.
6. Philip T, Ghalie R, Pinkerton CR. A phase II study of high dose cisplatin and VP16 in neuroblastoma. A report from the Société Française d'Oncologie Pédiatrique. J Clin Oncol 1987; 5: 941-50.
7. Hartmann O, Pinkerton CR, Phillip T, et al. Very high dose cisplatin and etoposide in children with untreated advanced neuroblastoma. J Clin Oncol 1988; 6: 44-50.
8. Pritchard J, Germond S, Jones D. Is high-dose melphalan of value in treatment of advanced neuroblastoma? Proc Am Soc Clin Oncol 1986; 5: A805.
9. Corbett R, Pinkerton CR, Pritchard J, et al. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 1992; 28 A: 1324-8.
10. Gordon SJ, Pearson ADJ, Reid M, et al. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 1992; 28 A: 1319-23.
11. Emminger W, Emminger-Schmideler W, Hawliczek R, et al. High-dose melphalan, etoposide ± carboplatin (MEC) combined with 12 gray fractionated TBI in children with generalised solid tumours. Pediatr Hematol Oncol 1991; 8: 13-22.
12. Graham-Pole J, Casper J, Elfenbein G, et al. High-dose chemoradiotherapy supported by marrow infusion for advanced neuroblastoma. A Paediatric Oncology Group study. J Clin Oncol 1991; 9: 152-8.
13. Seeger RC, Reynolds CP, Stram D, et al. Intensive chemoradiotherapy and ABMT for high-risk neuroblastoma. Bone Marrow Transplant 1994; 14: 1, S63.
14. Philip T, Zucker JM, Bernard JL, et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 1991; 5: 1037-44.
15. Graham-Pole J. Is there an advantage to allogeneic over autologous marrow transplantation in patients with metastatic neuroblastoma? Proc 18th Meeting, International Society of Experimental Haematology, Paris 1989: 586 (Abstract).
16. Negrier S, Ranchere JY, Philip I, et al. Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multi-centric French pilot study. Bone Marrow Transplant 1991; 8: 259-64.
17. Favrot MC, Floret D, Negrier S, et al. Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation. Bone Marrow Transplant 1989; 4: 499-504.
18. Jürgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of an European Co-operative Trial. Cancer 1988; 61: 23-32.
19. Burgert EO Jr, Nesbit ME, Garnsey LA, Gehan EA, et al. Multimodal therapy for the management of nonpelvis, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990; 8; 1514-24.
20. Craft AW, Cotterill S, Imeson J. Improvement in survival for Ewing's sarcoma by substitutioin of ifosfamide for cyclophosphamide: A UKCCSG/MRC study. Am J Pediatr Hematol Oncol 1993; 15 (Suppl A): S31-5.
21. Hartmann O, Oberlin O, Beaujean F, et al. Place de la chimio-therapie a hautes doses suivié d'autogreffe medullaire dans le traitement des sarcomes d'Ewing metastatiques de l'enfant. Bull Cancer (Paris) 1990; 77: 181-7.
22. Burdach St, Jürgens H, Peters C, et al. Myeloablative radio-chemotherapy and haemopoietic stem-cell rescue in poor prognosis Ewing's sarcoma. J Clin Oncol 1993; 11: 1482-8.
23. Hartmann O, Benhamou E, Beaujean F. High-dose busulphan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. J Clin Oncol 1986; 4: 1804-10.
24. Horowitz, ME, Kinsella TJ, Wexler LH, et al. Total body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 1993; 11: 1911-8.
25. Ladenstein R, Lasset C, Pinkerton CR, et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995; 15: 697-705.
26. Belasco JB, Mitchell CD, Rohrbaugh T, et al. IV melphalan in children. Cancer Treat Rep 1987; 71: 1277-8.
27. Hartmann O, Vassal G, Valteau D, et al. Autologous bone marrow transplantation in pediatric solid tumours: phase II studies. Bone Marrow Transplant 1991; 7: 106-11.
28. Pinkerton CR, Groot-Loonen J, Barrett A, et al. Rapid VAC, high dose melphalan regimen. A novel chemotherapy approach in childhood soft tissue sarcomas. Br J Cancer 1991; 64: 381-5.
29. Pinkerton CR. Megatherapy for soft tissue sarcomas. EBMT experience. Bone Marrow Transplant 1991; 7: 120-2.
30. Grundi P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ. Prognostic factors for children with recurrent Wilms' tumour: results from the second and third national Wilms' tumour study. J Clin Oncol 1989; 7: 638-47.
31. Groot-Loonen JJ, Pinkerton CR, Morris-Jones PJ, Pritchard J. How curable is relapsed Wilms' tumour? Arch Dis Child 1990; 65: 968-70.
32. Bagnulo S, Perez DJ, Barrett A, et al. High dose melphalan and autologous bone marrow transplantation for solid tumours in childhood. Eur J Paed Haem Oncol 1985; 1: 129.
33. Garavanta A, Hartmann O, Bernard JL, et al. ABMT for Wilms' tumour: EBMT experience. Bone Marrow Transplant 1991; 7: 118-9.
34. Phillips GL, Wolff SN, Fay JW, et al. Intensive, 1: 3-bis (2-chloroethyl)1-1nitrosurea (BCNU) monotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 1986; 4: 639-45.
35. Heideman RL, Douglass EC, Krance RA, et al. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 1993; 8: 1458-65.
36. Saarinen UM, Hovi L, Mäkipernaa A, Riikonen P. High dose thiotepa with autologous bone marrow rescue in pediatric solid tumours. Bone Marrow Transplant 1991; 8: 369-76.
37. Kalifa C, Hartmann O, Democq F, et al. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumours; a phase II study. Bone Marrow Transplant 1992; 9: 227-33.
38. Abrahamsen TG, Lange BJ, Packer RJ, et al. A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumours. Pediatr Hematol Oncol 1995; 17: 134-9.
39. Moghrabi A, Fuchs H, Brown M, et al. Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med Pediatr Oncol 1995; 25: 190-6.
40. Harstrick A, Schmoll H-J, Wilke H, et al. Cisplatin, etoposide and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 1991; 9: 1549-55.
41. Motzer RJ, Cooper K, Geller NL, et al. The role of ifosfamide plus cisplatin based chemotherapy as salvage therapy for patients with refractory germ cell tumours. Cancer 1990; 66: 2476-81.
42. Siegert W, Beyer J, Strohscheer I, et al. High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 1994; 6: 1223-31.
43. Droz JP, Pico JL, Biron P, Kramar A, Culine S. French experience with high dose chemotherapy and haemopoietic stem-cell support in germ cell tumours. Bone Marrow Transplant 1994; 14: S39-40.